首页|微小RNA-148a-3p靶向核心1β13-半乳糖基转移酶1增强肺腺癌细胞的放疗敏感性的研究

微小RNA-148a-3p靶向核心1β13-半乳糖基转移酶1增强肺腺癌细胞的放疗敏感性的研究

扫码查看
目的 探讨微小RNA-148a-3p(miR-148a-3p)在肺腺癌中的表达及临床意义,分析miR-148a-3p靶向蛋白核心1β13-半乳糖基转移酶1(C1GALT1)对肺腺癌细胞放疗敏感性的影响及机制。方法 选取肺腺癌组织芯片中76例患者肿瘤组织及肺腺癌A549细胞株为研究对象。对组织芯片分别进行miR-148a-3p原位杂交(ISH)染色和C1GALT1免疫组织化学染色,分析76例肺腺癌患者肿瘤组织中miR-148a-3p的表达与临床病理、预后及C1GALT1表达的关系。采用细胞转染技术对A549细胞进行miR-148a-3p过表达质粒的转染;转染细胞接受2 Gy放疗后采用克隆形成实验检测细胞的放疗敏感性;采用蛋白质印迹法检测细胞C1GALT1蛋白表达水平;采用双荧光素酶报告基因实验验证miR-148a-3p与C1GALT1的靶向调控关系;采用共转染技术分析miR-148a-3p调控A549细胞放疗敏感性的机制。结果 76例肺腺癌组织中低表达miR-148a-3p与患者淋巴结转移显著相关(P=0。012);miR-148a-3p高表达者预后显著优于miR-148a-3p低表达者(P=0。005);肺腺癌组织中miR-148a-3p与C1GALT1的表达呈显著负相关(P=0。023)。多因素分析显示,miR-148a-3p低表达、T分期及淋巴结转移是预后的独立危险因素。克隆形成实验显示,过表达miR-148a-3p组克隆形成数显著低于对照组(P<0。001);Western Blot结果显示,miR-148a-3p过表达可以显著下调细胞中C1GALT1蛋白水平(P<0。001)。双荧光素酶报告基因实验显示miR-148a-3p通过结合C1GALT1的3'UTR来调控C1GALT1的表达。功能拯救试验显示C1GALT1能够部分抵消miR-148a-3p的放疗增敏效应。结论 肺腺癌中miR-148a-3p低表达与淋巴结转移、C1GALT1高表达及预后不良显著相关,miR-148a-3p通过负调控C1GALT1的表达增强肺腺癌细胞的放疗敏感性。
MicroRNA-148a-3p enhances sensitivity of radiotherapy of lung adenocarcinoma cells by targeting core 1β13-galactosyltransferase 1
Objective To investigate the expression and clinical significance of microRNA-148a-3p(miR-148a-3p)in lung adenocarcinoma and analyze the effect and mechanism of miR-148a-3p on ra-diotherapy sensitivity of lung adenocarcinoma cells by targeting the protein core 1 β13-galactosyltrans-ferase 1(C1GALT1).Methods Seventy-six patients'tumor tissues from lung adenocarcinoma tissue microarrays and lung adenocarcinoma A549 cell line were selected for the study.The miR-148a-3p in situ hybridizations(ISH)and C1GALT1 immunohistochemical staining were performed on the tissue microarrays to analyze the correlations of miR-148a-3p expression with clinical pathology,prognosis and C1GALT1 expression in the tumor tissues of the 76 patients with lung adenocarcinoma.A549 cells were transfected with miR-148a-3p overexpression plasmid by using cell transfection technique;the clone formation assay was used to detect the sensitivity of the transfected cells for radiotherapy after re-ceiving 2 Gy radiotherapy;the protein expression level of cellular C1GALT1 was detected by western blot;the targeted regulatory relationship between miR-148a-3p and C1GALT1 was verified by dual-luciferase reporter gene experiment;the mechanism of miR-148a-3p regulating the sensitivity of A549 cells to radiotherapy was analyzed by co-transfection technique.Results Low expression of miR-148a-3p in 76 cases of lung adenocarcinoma tissues was significantly associated with lymph node metastasis(P=0.012);the prognosis of patients with high expression of miR-148a-3p was significantly better than that of patients with low expression of miR-148a-3p(P=0.005);there was a significant negative correlation between the expression of miR-148a-3p and C1GALT1 in lung adenocarcinoma tissues(P=0.023).Multivariate analysis showed that low expression of miR-148a-3p,T staging and lymph node metastasis were the independent risk factors for prognosis.Clone formation experiment showed that the number of clone formation in the miR-148a-3p overexpression group was significantly lower than that in the control group(P<0.001);western blot result showed that overexpression of miR-148a-3p was able to significantly down-regulate the level of C1GALT1 protein in cells(P<0.001).Dual luciferase reporter gene experiment showed that miR-148a-3p was able to regulate the expression of C1GALT1 by binding to the 3'UTR of C1GALT1.Functional rescue experiment showed that C1GALT1 could partially offset the radiosensitization effect of miR-148a-3p.Conclusion Low ex-pression of miR-148a-3p in lung adenocarcinoma is significantly associated with lymph node metasta-sis,high expression of C1GALT1 and poor prognosis,and miR-148a-3p can enhance the radiosensitiv-ity of lung adenocarcinoma cells by negatively regulating the expression of C1GALT1.

microRNA-148a-3pcore 1β13-galactosyltransferase 1lung adenocarcinomaradiotherapy sensitivityprognosis

申霖、任粤、邓一洲、殷旭东、陈勇

展开 >

扬州大学附属医院肿瘤科,江苏扬州,225000

微小RNA-148a-3p 核心1β13-半乳糖基转移酶1 肺腺癌 放疗敏感性 预后

江苏省自然科学基金项目江苏省扬州市社会发展项目直线加速器的数据验证与性能评价

BK20191218YZ2021081BY20221106

2024

实用临床医药杂志
扬州大学,中国高校科技期刊研究会

实用临床医药杂志

CSTPCD
影响因子:1.543
ISSN:1672-2353
年,卷(期):2024.28(6)
  • 25